<DOC>
	<DOCNO>NCT03044639</DOCNO>
	<brief_summary>The randomize , double-blind , multi-centric study perform four parallel group compare lipid emulsion , use part PN . Patients home parenteral nutrition due stable intestinal failure , randomly assign receive parenteral nutrition one follow lipid emulsion : - Long-chained triglyceride ( LCT group ) - Medium/ long-chained triglyceride MCT/LCT ( 50:50 , MCT/LCT group ) ) - Olive oil/ LCT ( 80:20 , OO group ) ) - SMOFlipid ( Omega-3/ olive oil/ MCT/ LCT , SMOF group )</brief_summary>
	<brief_title>Parenteral Lipid Emulsions Liver Function</brief_title>
	<detailed_description>Intravenous lipid emulsion ( IVLE ) essential component parenteral nutrition ( PN ) , efficient source energy essential fatty acid ( FA ) .The prevalence abnormal liver function test PN vary 15 85 % , accord author . [ 19-21 ] The severity IFALD depend also underlying disease , especially ongoing sepsis pre-existing liver disease . A study compare lipid emulsion , use part PN , never do . The aim study compare clinical value four popular intravenous lipid emulsion regard liver function long term intestinal failure patients.Patients home parenteral nutrition due stable intestinal failure , randomly assign receive parenteral nutrition one follow lipid emulsion : - Long-chained triglyceride ( LCT group ) - Medium/ long-chained triglyceride MCT/LCT ( 50:50 , MCT/LCT group ) ) - Olive oil/ LCT ( 80:20 , OO group ) ) - SMOFlipid ( Omega-3/ olive oil/ MCT/ LCT , SMOF group ) Randomization perform assessment check in-/exclusion criterion patient meet study eligibility requirement . The test emulsion become part regular PN admixture , use feed patient home . The study perform 12 month .</detailed_description>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Fat Emulsions , Intravenous</mesh_term>
	<criteria>1. chronic intestinal failure ( CIF ) receive HPN include lipid 2. metabolic stability HPN three month ( metabolic stability = absence pathological laboratory result change PN regime least one month ) 3 . 1.0 g lipids/kg body weight per day part PN 1 . Existing liver failure : elevation SGOT , SGTP , total bilirubin , GGTP , alkaline phosphatase 1.5 time x normal value 2 . Patients PN interrupt long 4 continuous week precede 6 month 3 . Patients history cancer anticancer treatment within last 5 year 4 . Severe hyperlipidemia 5 . Severe coagulopathy 6 . Severe renal insufficiency 7 . Acute thromboembolic event 8 . Positive test HIV , Hepatitis B C ( medical history ) 9 . Known suspected drug alcohol abuse 10 . Participation another interventional clinical trial parallel within three month prior start clinical trial 11 . For woman childbearing potential ( i.e . female chemically surgically sterile female postmenopausal ) woman childbearing potential test positive standard pregnancy test ( urine dipstick ) or/ lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>